734-936-8000 - Service Desk | Request Support

Advances in Gastroenterology and Hepatology (On-Demand)

To begin this activity, click Enroll. Once logged in, learners can access educational content, assessments, and evaluations. Learners who successfully complete the activity will be able to print a certificate.

Step Status
Educational Materials
Release Date: Sat, 1/1/22
Termination Date: Sat, 12/31/22
Credits: 6.25

Educational Content from the Live Conference held on February 7 - 9, 2020

Planner: Michael D Rice, MD

Co-Planner: Richard J Saad, MD

Coordinators: Allison Picinotti, Emily Vandervoort, Erin Reau


  • Alcoholic Liver Disease | Jessica L Mellinger, MD, PhD
  • Endoscopy in the Management of Small Bowel Bleeding | Michael D Rice, MD
  • Periprocedural Management of Anti-Platelets & Anti-Coagulant Therapy | Michelle A Anderson, MD
  • Pancreatic Cystic Neoplasms | Richard S Kwon, MD
  • Drug and Herbal Hepatotoxicity | Robert J Fontana, MD
  • Management of CIC and IBS-C | William D Chey, MD
  • Gastroparesis | William Hasler, MD
  • Small Intestinal Bacterial Overgrowth (SIBO): Current Guidelines | Richard J Saad, MD
  • Current Management of Crohn’s Disease | Peter D Higgins, MD, PhD
  • Severe Inflammatory Bowel Disease: Prevention and Management Strategies | Ryan Stidham, MD, MS

Financial Disclosure Information:

There are no other relevant financial relationships with ACCME-defined commercial interests to disclose for this activity.

In accordance with Michigan Medicine policy, all conflicts of interest are resolved by peer-review of the educational content to ensure there is no discussion or recommendations for specific products, and/or products/services are described in generic terms only.

Educational Objectives: At the end of this activity, participant should be able to:
  1. be able to implement treatment options for patients with H Pylori.
  2. learn more about the current guidelines in SIBO treatment
  3. be able to describe the current landscape for management of Crohns.
  4. better understand prevention and management strategies for patients with severe IBD.
  5. learn about recent updates in chronic HBV.
Target Audience: This activity is appropriate for Medical Students, Nurse Practitioners, Nurses, Other Healthcare Professionals, Physician Assistants, Physicians in the fields of Gastroenterology, General Medicine, Hepatology, Immunology, Internal Medicine, Primary Care, Transplant Surgery.
Accreditation and Credit Designation:

The University of Michigan Medical School is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The University of Michigan Medical School designates this enduring material for a maximum of 6.25 AMA PRA Category 1 Credit(s) ™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 6.25 Medical Knowledge MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

Additional Info: Bibliographic Resources

D’Haens, et al. Lancet 2008
Siegel CA, et al. J Crohns Colitis 2017
Peyrin-Biroulet L et al, CGH 2016

Credits available:

AMA PRA Category 1: 6.25
Participation: 6.25